NPHLA Tracker · Compounding regulatory tracker (Federal Register / FDA)
Compounding Regulatory Tracker
Official federal records on drug compounding — Federal Register rules, proposed rules and notices, FDA announcements and safety alerts, and FDA enforcement-report recalls — tagged to 503A, 503B, GLP-1 compounding, USP standards, peptides and enforcement.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
- Records
- 98
- Changed in 7 days
- 6
- Latest record
- Jurisdiction
- United States (federal)
Records
6 changed in the last 7 days| Record | Status | Record type | Jurisdiction | Date | Source | Last checked |
|---|---|---|---|---|---|---|
| Medline Updates Customers and Patients on Repair and Replace Program for Recall of Medline Brand Beds, Rails, Mattresses and AccessoriesChanged in the last 7 days Recall published in the FDA Enforcement Report · On October 14, 2026, Medline initiated a product recall, market exit and discontinuation of all Medline Brand beds, rails, mattresses, and accessories (e.g., pendants and motor boxes) due to a potential fire hazard and entrapment risk, whi… | Recall | Recall | United States (federal) | Enforcement report date | U.S. Food and Drug Administration: Medline Updates Customers and Patients on Repair and Replace Program for Recall of Medline Brand Beds, Rails, Mattresses and Accessories (opens in a new tab)Official record | System checked NPHLA updated |
| Eros Apothecary Issues Recall of Candy Power For Man Organic Honey Due to Undeclared TadalafilChanged in the last 7 days Recall published in the FDA Enforcement Report · Eros Apothecary of Indio, California is recalling Candy Power For Man Organic Honey because the product was found to contain undeclared tadalafil. | Recall | Recall | United States (federal) | Enforcement report date | U.S. Food and Drug Administration: Eros Apothecary Issues Recall of Candy Power For Man Organic Honey Due to Undeclared Tadalafil (opens in a new tab)Official record | System checked NPHLA updated |
| Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and AcetaminophenChanged in the last 7 days Safety alert published · FOR IMMEDIATE RELEASE – November 12, 2026 - Tampa, Florida. Game Changer Products LLC is voluntarily recalling all lots of 10 Day Forecast capsules to the consumer level. FDA analysis has found the product to be tainted with sildenafil and… | Safety alert | Safety alert | United States (federal) | Published | U.S. Food and Drug Administration (MedWatch): Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophen (opens in a new tab)Official record | System checked NPHLA updated |
| Family Farmstead Dairy Announces Recall of All Cheddar Cheese Products Because of Possible Health RiskChanged in the last 7 days Recall published in the FDA Enforcement Report · Worcester, New York – Family Farmstead Dairy is recalling all cheddar cheese products because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young… | Recall | Recall | United States (federal) | Enforcement report date | U.S. Food and Drug Administration: Family Farmstead Dairy Announces Recall of All Cheddar Cheese Products Because of Possible Health Risk (opens in a new tab)Official record | System checked NPHLA updated |
| MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety CommunicationChanged in the last 7 days Safety alert published · FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication | Safety alert | Safety alert | United States (federal) | Published | U.S. Food and Drug Administration (MedWatch): MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication (opens in a new tab)Official record | System checked NPHLA updated |
| Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers (AIC)Changed in the last 7 days Safety alert published · Abiomed is removing certain Impella Controllers with various hardware, firmware, and/or software updates based on a retrospective review of servicing records. | Safety alert | Safety alert | United States (federal) | Published | U.S. Food and Drug Administration (MedWatch): Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers (AIC) (opens in a new tab)Official record | System checked NPHLA updated |
How is this tracker compiled?
The Intelligence pipeline collects official records from the Federal Register API (including a dedicated FDA compounding search), FDA press announcements, MedWatch safety alerts and recall feeds, and openFDA enforcement reports (including a search for recalls of compounded drugs). Each record is classified against the knowledge graph by matching topic names and keywords in its title and summary.
This tracker lists records from primary sources tagged with a compounding topic. News and trade-press items are excluded.
Selection: Official records (final rule, proposed rule, notice, recall, press release and safety alert) from primary sources tagged “503a”, “503b”, “glp1-compounding”, “usp-compounding”, “peptides” and “compounding-enforcement” in the NPHLA knowledge graph.
What does it cover?
U.S. federal records (FDA and the Federal Register) published since tracking of each source began. State board actions and documents FDA publishes only on its website, such as warning letters, are not yet included.
What are its limitations?
Classification is automatic and keyword-based: a record can be missed if it does not use the tracked terms, and a record can occasionally be tagged to a topic it mentions only in passing. Recall records name the firms involved exactly as FDA publishes them. Not legal advice — read the official document.
How often is it updated?
Sources are checked every 1 to 6 hours depending on the source, as configured in the Source Registry.
System checked is the last time an automated check of the underlying official sources succeeded — it is not a human review. Editorially reviewed appears only when an editor has reviewed this tracker. Each row shows its own check: an automated system check or an editor’s verification.
Data origin: NPHLA analysis of public data. Professional reference only — not medical, legal or regulatory advice. Always confirm a record in its primary source. Spotted an error? Tell us.